💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for GTx, Inc. (GTXI)
« Back to company indexGTXI Chatter Timeline
Stock Ticker for GTXI
Most Active Tweeters for GTXI
| User | Tweets |
|---|---|
| @TradHewk | 1 |
Recent Tweets for GTXI
 |
@TradHewk RT @TradeHawk: $GTXI GTx Inc merger with Oncternal has been approved by stockholders https://t.co/GCPTeDqEZ7 October 30th 2020, 6:10pm |
 |
@__jpark89 RT @_jpark89: Happy to say I made back all losses from yesterday with a bulk of gains coming from this trade on $GTXI Great end to an acti… October 14th 2020, 5:10am |
 |
@Allstocknews $GTXI Oncternal Therapeutics Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administrati From our Stock News Alerts App October 6th 2020, 8:10am |
|
@Allstocknews $GTXI Oncternal Therapeutics Announces Presentation of Interim Phase 1 Clinical Trial Data for TK216 in Patie From our Stock News Alerts App September 21st 2020, 8:09am |
|
@Allstocknews $GTXI Oncternal Therapeutics to Participate in September Investor Conferences From our Stock News Alerts App September 10th 2020, 8:09am |
 |
@EdgarInsider FORM 8-K [Press/News Current Report] recently SEC filed. $ONCT $GTXI #OncternalTherapeutics, Inc https://t.co/wzs44HJakh August 31st 2020, 9:08pm |
 |
@BeefEnt My thoughts on low float shorts. $GTXI https://t.co/WRCReLgNDs via @YouTube @tim August 29th 2020, 8:08pm |
 |
@FlashAlert_me $GTXI [15s. delayed] filed form FWP on August 27, 21:34:58 https://t.co/ZsHiqruUTI August 28th 2020, 6:08am |
|
@Allstocknews $GTXI Oncternal Therapeutics Increases Previously Announced Bought Deal to $4.5 Million From our Stock News Alerts App August 27th 2020, 9:08pm |
|
@Allstocknews $GTXI New Form FWP for Oncternal Therapeutics, Inc. From our Stock News Alerts App August 27th 2020, 5:08pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed form FWP on August 27, 17:26:59 https://t.co/XbOwhnH7QE August 27th 2020, 5:08pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed form 424B5 on August 27, 17:24:28 https://t.co/mLXSIzkRY3 August 27th 2020, 5:08pm |
|
@Allstocknews $GTXI Oncternal Therapeutics Announces $3.5 Million Bought Deal Offering From our Stock News Alerts App August 27th 2020, 5:08pm |
|
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $ONCT $GTXI #OncternalTherapeutics, Inc https://t.co/cRYk569MXu August 27th 2020, 4:08pm |
|
@EdgarInsider Alert [Press/News Current Report] / Form 8-K filed with the SEC $ONCT $GTXI #OncternalTherapeutics, Inc https://t.co/qzfVZOIRqC August 6th 2020, 9:08pm |
|
@EdgarInsider New Form 10-Q [Quarterly Report] entry filed by $ONCT $GTXI #OncternalTherapeutics, Inc https://t.co/UN1Jp7Oy18 August 6th 2020, 6:08pm |
|
@Allstocknews $GTXI New Form 10-Q for Oncternal Therapeutics, Inc. From our Stock News Alerts App August 6th 2020, 4:08pm |
|
@Allstocknews $GTXI Oncternal Provides Business Update and Announces Second Quarter 2020 Financial Results From our Stock News Alerts App August 6th 2020, 4:08pm |
|
@Allstocknews $GTXI New Form D for Oncternal Therapeutics, Inc. From our Stock News Alerts App August 3rd 2020, 6:08am |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director THEUER CHARLES: Transacted Derivative Securities on 2020-06-11. https://t.co/yrDnLwYn9H July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director Wills Robert James: Transacted Derivative Securities on 2019-09-… https://t.co/FbnaFN3DVN July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director Nakanishi Xin: Transacted Derivative Securities on 2019-09-12. https://t.co/8mrc6qQOjU July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Scientific Officer Kaufmann Gunnar F.: Transacted Derivative Securi… https://t.co/WK1A8QYocT July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director LARUE WILLIAM R: Transacted Derivative Securities on 2020-06-11. https://t.co/KlKnG8njUF July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director CARTER MICHAEL G: Transacted Derivative Securities on 2020-06-11… https://t.co/5itfmXaWty July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director Wills Robert James: Transacted Derivative Securities on 2020-06-… https://t.co/ULk5HFyD5m July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director LARUE WILLIAM R: Transacted Derivative Securities on 2019-09-12. https://t.co/bv3sth7oy4 July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director HALE DAVID F: Transacted Derivative Securities on 2020-06-11. https://t.co/duld23A19R July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director Nakanishi Xin: Transacted Derivative Securities on 2020-06-11. https://t.co/dhVUQ1oTbU July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Financial Officer VINCENT RICHARD G: Transacted Derivative Securiti… https://t.co/lcpQXIpivE July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director KISNER DANIEL L: Transacted Derivative Securities on 2019-09-12. https://t.co/WTNfn8WBHB July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director HALE DAVID F: Transacted Derivative Securities on 2019-09-12. https://t.co/TQGGPZpWgG July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Scientific Officer Kaufmann Gunnar F.: Transacted Derivative Securi… https://t.co/Q6l0w6Zz5t July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Business Officer BILINSKY IGOR: Transacted Derivative Securities on… https://t.co/KaJdCCXBMt July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director KISNER DANIEL L: Transacted Derivative Securities on 2020-06-11. https://t.co/eBlnXAnY3K July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Financial Officer VINCENT RICHARD G: Transacted Derivative Securiti… https://t.co/azFgpeDkDY July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director THEUER CHARLES: Transacted Derivative Securities on 2019-09-12. https://t.co/wb5jk5eHop July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Executive Officer BREITMEYER JAMES B: Transacted Derivative Securit… https://t.co/kNB3Hb3MdA July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director Liu Yanjun: Transacted Derivative Securities on 2019-09-12. https://t.co/M54V33i3CV July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director Cho Man: Transacted Derivative Securities on 2020-06-11. https://t.co/LPSsBVzD2c July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Medical Officer Hsu Frank J.: Transacted Derivative Securities on 2… https://t.co/uz54VX65xl July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director Cho Man: Transacted Derivative Securities on 2019-12-18. https://t.co/cL5Fc5TdPe July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Medical Officer Hsu Frank J.: Transacted Derivative Securities on 2… https://t.co/HTqeCVaRqf July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Legal Counsel AKER HAZEL M: Transacted Derivative Securities on 2020-03-1… https://t.co/kaL2YoWJgb July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Legal Counsel AKER HAZEL M: Transacted Derivative Securities on 2019-09-1… https://t.co/txErPZ05fZ July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Executive Officer BREITMEYER JAMES B: Transacted Derivative Securit… https://t.co/uuuKDKyf6P July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Director CARTER MICHAEL G: Transacted Derivative Securities on 2019-09-12… https://t.co/cEakpYgm0L July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Executive Officer BREITMEYER JAMES B: Transacted Derivative Securit… https://t.co/BXOfzlG970 July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Chief Business Officer BILINSKY IGOR: Transacted Derivative Securities on… https://t.co/KDsRwWf9uq July 31st 2020, 9:07pm |
|
@FlashAlert_me $GTXI [15s. delayed] filed SEC form 4/A: Legal Counsel AKER HAZEL M: Transacted Derivative Securities on 2019-09-1… https://t.co/rqbEc0eDro July 31st 2020, 9:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
